Report Detail
Global Capecitabine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
- RnM3112479 |
- 12 March, 2019 |
- Global |
- 119 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Scope of the Report:
Capecitabine is a prescription medication used to treat breast cancer and cancer of the colon or rectum. Capecitabine belongs to a group of drugs called antimetabolites which work by interfering with DNA production, stopping cells from multiplying. The medication comes in tablet form and is usually taken twice daily, within 30 minutes after the end of a meal. The proportion of breast cancer with Handle in 2016 is about 40%, and the proportion of colorectal cancer in 2016 is about 31.94%.
Cancer clinical treatment projects have led to the increasing demand for Capecitabine. Increasing Cancer incidence across the globe, especially in the Asia-Pacific is another major factor, driving the growth of the Capecitabine market during the forecast period.
The worldwide market for Capecitabine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
500 mg
150 mg
Market Segment by Applications, can be divided into
Breast Cancer
Colorectal Cancer
Stomach Cancer
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Capecitabine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Capecitabine, with price, sales, revenue and global market share of Capecitabine in 2017 and 2018.
Chapter 3, the Capecitabine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Capecitabine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Capecitabine market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Capecitabine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
- 1.1 Capecitabine Introduction
- 1.2 Market Analysis by Type
- 1.2.1 500 mg
- 1.2.2 150 mg
- 1.3 Market Analysis by Applications
- 1.3.1 Breast Cancer
- 1.3.2 Colorectal Cancer
- 1.3.3 Stomach Cancer
- 1.4 Market Analysis by Regions
- 1.4.1 North America (United States, Canada and Mexico)
- 1.4.1.1 United States Market States and Outlook (2014-2024)
- 1.4.1.2 Canada Market States and Outlook (2014-2024)
- 1.4.1.3 Mexico Market States and Outlook (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy)
- 1.4.2.1 Germany Market States and Outlook (2014-2024)
- 1.4.2.2 France Market States and Outlook (2014-2024)
- 1.4.2.3 UK Market States and Outlook (2014-2024)
- 1.4.2.4 Russia Market States and Outlook (2014-2024)
- 1.4.2.5 Italy Market States and Outlook (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- 1.4.3.1 China Market States and Outlook (2014-2024)
- 1.4.3.2 Japan Market States and Outlook (2014-2024)
- 1.4.3.3 Korea Market States and Outlook (2014-2024)
- 1.4.3.4 India Market States and Outlook (2014-2024)
- 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
- 1.4.4 South America, Middle East and Africa
- 1.4.4.1 Brazil Market States and Outlook (2014-2024)
- 1.4.4.2 Egypt Market States and Outlook (2014-2024)
- 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
- 1.4.4.4 South Africa Market States and Outlook (2014-2024)
- 1.4.4.5 Turkey Market States and Outlook (2014-2024)
- 1.4.1 North America (United States, Canada and Mexico)
- 1.5 Market Dynamics
- 1.5.1 Market Opportunities
- 1.5.2 Market Risk
- 1.5.3 Market Driving Force
2 Manufacturers Profiles
- 2.1 Roche
- 2.1.1 Business Overview
- 2.1.2 Capecitabine Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 Roche Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Teva
- 2.2.1 Business Overview
- 2.2.2 Capecitabine Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Teva Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Mylan
- 2.3.1 Business Overview
- 2.3.2 Capecitabine Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Mylan Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 Hikma
- 2.4.1 Business Overview
- 2.4.2 Capecitabine Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 Hikma Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Hengrui Medicine
- 2.5.1 Business Overview
- 2.5.2 Capecitabine Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Hengrui Medicine Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Cipla
- 2.6.1 Business Overview
- 2.6.2 Capecitabine Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Cipla Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Reliance Group
- 2.7.1 Business Overview
- 2.7.2 Capecitabine Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Reliance Group Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 Hetero
- 2.8.1 Business Overview
- 2.8.2 Capecitabine Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 Hetero Capecitabine Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Capecitabine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
- 3.1 Global Capecitabine Sales and Market Share by Manufacturer (2017-2018)
- 3.2 Global Capecitabine Revenue and Market Share by Manufacturer (2017-2018)
- 3.3 Market Concentration Rate
- 3.3.1 Top 3 Capecitabine Manufacturer Market Share in 2018
- 3.3.2 Top 6 Capecitabine Manufacturer Market Share in 2018
- 3.4 Market Competition Trend
4 Global Capecitabine Market Analysis by Regions
- 4.1 Global Capecitabine Sales, Revenue and Market Share by Regions
- 4.1.1 Global Capecitabine Sales and Market Share by Regions (2014-2019)
- 4.1.2 Global Capecitabine Revenue and Market Share by Regions (2014-2019)
- 4.2 North America Capecitabine Sales and Growth Rate (2014-2019)
- 4.3 Europe Capecitabine Sales and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Capecitabine Sales and Growth Rate (2014-2019)
- 4.5 South America Capecitabine Sales and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Capecitabine Sales and Growth Rate (2014-2019)
5 North America Capecitabine by Country
- 5.1 North America Capecitabine Sales, Revenue and Market Share by Country
- 5.1.1 North America Capecitabine Sales and Market Share by Country (2014-2019)
- 5.1.2 North America Capecitabine Revenue and Market Share by Country (2014-2019)
- 5.2 United States Capecitabine Sales and Growth Rate (2014-2019)
- 5.3 Canada Capecitabine Sales and Growth Rate (2014-2019)
- 5.4 Mexico Capecitabine Sales and Growth Rate (2014-2019)
6 Europe Capecitabine by Country
- 6.1 Europe Capecitabine Sales, Revenue and Market Share by Country
- 6.1.1 Europe Capecitabine Sales and Market Share by Country (2014-2019)
- 6.1.2 Europe Capecitabine Revenue and Market Share by Country (2014-2019)
- 6.2 Germany Capecitabine Sales and Growth Rate (2014-2019)
- 6.3 UK Capecitabine Sales and Growth Rate (2014-2019)
- 6.4 France Capecitabine Sales and Growth Rate (2014-2019)
- 6.5 Russia Capecitabine Sales and Growth Rate (2014-2019)
- 6.6 Italy Capecitabine Sales and Growth Rate (2014-2019)
7 Asia-Pacific Capecitabine by Country
- 7.1 Asia-Pacific Capecitabine Sales, Revenue and Market Share by Country
- 7.1.1 Asia-Pacific Capecitabine Sales and Market Share by Country (2014-2019)
- 7.1.2 Asia-Pacific Capecitabine Revenue and Market Share by Country (2014-2019)
- 7.2 China Capecitabine Sales and Growth Rate (2014-2019)
- 7.3 Japan Capecitabine Sales and Growth Rate (2014-2019)
- 7.4 Korea Capecitabine Sales and Growth Rate (2014-2019)
- 7.5 India Capecitabine Sales and Growth Rate (2014-2019)
- 7.6 Southeast Asia Capecitabine Sales and Growth Rate (2014-2019)
8 South America Capecitabine by Country
- 8.1 South America Capecitabine Sales, Revenue and Market Share by Country
- 8.1.1 South America Capecitabine Sales and Market Share by Country (2014-2019)
- 8.1.2 South America Capecitabine Revenue and Market Share by Country (2014-2019)
- 8.2 Brazil Capecitabine Sales and Growth Rate (2014-2019)
- 8.3 Argentina Capecitabine Sales and Growth Rate (2014-2019)
- 8.4 Colombia Capecitabine Sales and Growth Rate (2014-2019)
9 Middle East and Africa Capecitabine by Countries
- 9.1 Middle East and Africa Capecitabine Sales, Revenue and Market Share by Country
- 9.1.1 Middle East and Africa Capecitabine Sales and Market Share by Country (2014-2019)
- 9.1.2 Middle East and Africa Capecitabine Revenue and Market Share by Country (2014-2019)
- 9.2 Saudi Arabia Capecitabine Sales and Growth Rate (2014-2019)
- 9.3 Turkey Capecitabine Sales and Growth Rate (2014-2019)
- 9.4 Egypt Capecitabine Sales and Growth Rate (2014-2019)
- 9.5 Nigeria Capecitabine Sales and Growth Rate (2014-2019)
- 9.6 South Africa Capecitabine Sales and Growth Rate (2014-2019)
10 Global Capecitabine Market Segment by Type
- 10.1 Global Capecitabine Sales, Revenue and Market Share by Type (2014-2019)
- 10.1.1 Global Capecitabine Sales and Market Share by Type (2014-2019)
- 10.1.2 Global Capecitabine Revenue and Market Share by Type (2014-2019)
- 10.2 500 mg Sales Growth and Price
- 10.2.1 Global 500 mg Sales Growth (2014-2019)
- 10.2.2 Global 500 mg Price (2014-2019)
- 10.3 150 mg Sales Growth and Price
- 10.3.1 Global 150 mg Sales Growth (2014-2019)
- 10.3.2 Global 150 mg Price (2014-2019)
11 Global Capecitabine Market Segment by Application
- 11.1 Global Capecitabine Sales Market Share by Application (2014-2019)
- 11.2 Breast Cancer Sales Growth (2014-2019)
- 11.3 Colorectal Cancer Sales Growth (2014-2019)
- 11.4 Stomach Cancer Sales Growth (2014-2019)
12 Capecitabine Market Forecast (2019-2024)
- 12.1 Global Capecitabine Sales, Revenue and Growth Rate (2019-2024)
- 12.2 Capecitabine Market Forecast by Regions (2019-2024)
- 12.2.1 North America Capecitabine Market Forecast (2019-2024)
- 12.2.2 Europe Capecitabine Market Forecast (2019-2024)
- 12.2.3 Asia-Pacific Capecitabine Market Forecast (2019-2024)
- 12.2.4 South America Capecitabine Market Forecast (2019-2024)
- 12.2.5 Middle East and Africa Capecitabine Market Forecast (2019-2024)
- 12.3 Capecitabine Market Forecast by Type (2019-2024)
- 12.3.1 Global Capecitabine Sales Forecast by Type (2019-2024)
- 12.3.2 Global Capecitabine Market Share Forecast by Type (2019-2024)
- 12.4 Capecitabine Market Forecast by Application (2019-2024)
- 12.4.1 Global Capecitabine Sales Forecast by Application (2019-2024)
- 12.4.2 Global Capecitabine Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
- 13.1 Sales Channel
- 13.1.1 Direct Marketing
- 13.1.2 Indirect Marketing
- 13.1.3 Marketing Channel Future Trend
- 13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
- 15.1 Methodology
Summary:
Get latest Market Research Reports on Capecitabine. Industry analysis & Market Report on Capecitabine is a syndicated market report, published as Global Capecitabine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Capecitabine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
